AllianceBernstein
PVLA

AllianceBernstein’s Palvella Therapeutics PVLA Stock Holding History

AllianceBernstein’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6M Sell
253,168
-9,667
-4% -$1.17M 0.01% 763
2026
Q1 		$27.5M Sell
262,835
-6,192
-2% -$646K 0.01% 789
2025
Q4 		$28.2M Buy
+269,027
New +$22.9M 0.01% 823
2021
Q2 		– Sell
-726
Closed -$149K – 3427
2021
Q1 		$149K Hold
726
– – ﹤0.01% 3111
2020
Q4 		$145K Hold
726
– – ﹤0.01% 3059
2020
Q3 		$120K Sell
726
-45
-6% -$10.2K ﹤0.01% 3052
2020
Q2 		$191K Buy
771
+158
+26% +$36.9K ﹤0.01% 3016
2020
Q1 		$112K Buy
613
+84
+16% +$21.2K ﹤0.01% 2933
2019
Q4 		$153K Hold
529
– – ﹤0.01% 2977
2019
Q3 		$144K Sell
529
-2,376
-82% -$920K ﹤0.01% 3013
2019
Q2 		$1.09M Buy
2,905
+103
+4% +$30.7K ﹤0.01% 2281
2019
Q1 		$751K Sell
2,802
-95
-3% -$22.6K ﹤0.01% 2377
2018
Q4 		$617K Buy
2,897
+1,080
+59% +$335K ﹤0.01% 2390
2018
Q3 		$814K Buy
1,817
+48
+3% +$20.9K ﹤0.01% 2429
2018
Q2 		$717K Buy
1,769
+443
+33% +$211K ﹤0.01% 2462
2018
Q1 		$724K Buy
1,326
+1,116
+531% +$691K ﹤0.01% 2398
2017
Q4 		$127K Buy
210
+47
+29% +$21.9K ﹤0.01% 2939
2017
Q3 		$75K Hold
163
– – ﹤0.01% 3061
2017
Q2 		$66K Buy
+163
New +$47.6K ﹤0.01% 3119

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

AllianceBernstein's PVLA Position: Q2 2026 in Review

AllianceBernstein reduced its Palvella Therapeutics (PVLA) stake by 3.7% in Q2 2026, selling an estimated $1.17M and leaving 253,168 shares worth $31.6M. The position accounts for 0.01% of the portfolio, ranked #763.

AllianceBernstein first reported a position in PVLA in Q2 2017 and has held it in 19 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • AllianceBernstein held 253,168 shares of Palvella Therapeutics worth $31.6M as of Q2 2026.
  • AllianceBernstein sold 9,667 Palvella Therapeutics shares in Q2 2026, an estimated $1.17M.
  • Palvella Therapeutics made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #763 holding.
  • AllianceBernstein first reported a position in Palvella Therapeutics in Q2 2017 and has held it in 19 quarters since.
  • 197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.